398 related articles for article (PubMed ID: 20021950)
1. [Prognostic factors and outcome in patients with intrahepatic recurrence after hepatectomy for hepatocellular carcinoma].
Yang LT; Cheng XD; Du YA; Wang XB; Zhang YL; Guo JM
Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):612-6. PubMed ID: 20021950
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma.
Choi GH; Kim DH; Kang CM; Kim KS; Choi JS; Lee WJ; Kim BR
Ann Surg Oncol; 2008 Feb; 15(2):618-29. PubMed ID: 18004628
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study.
Kawano Y; Sasaki A; Kai S; Endo Y; Iwaki K; Uchida H; Shibata K; Ohta M; Kitano S
Eur J Surg Oncol; 2009 Feb; 35(2):174-9. PubMed ID: 18325724
[TBL] [Abstract][Full Text] [Related]
4. Appropriate liver resection type for patients with the American joint committee on cancer classification T1 and T2 hepatocellular carcinoma.
Hsieh CB; Chung KP; Chu CM; Yu JC; Hsieh HF; Chu HC; Yu CY; Chen TW
Eur J Surg Oncol; 2011 Jun; 37(6):497-504. PubMed ID: 21450438
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for local and distant recurrence of hepatocellular carcinomas after local ablation therapies.
Nouso K; Matsumoto E; Kobayashi Y; Nakamura S; Tanaka H; Osawa T; Ikeda H; Araki Y; Sakaguchi K; Shiratori Y
J Gastroenterol Hepatol; 2008 Mar; 23(3):453-8. PubMed ID: 17725599
[TBL] [Abstract][Full Text] [Related]
6. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma.
Ibrahim S; Roychowdhury A; Hean TK
Am J Surg; 2007 Jul; 194(1):17-22. PubMed ID: 17560903
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes after hepatectomy for recurrences after prior local ablation for hepatocellular carcinoma.
Sakata J; Shirai Y; Wakai T; Kaneko K; Hatakeyama K
Eur J Surg Oncol; 2008 Apr; 34(4):433-8. PubMed ID: 17475439
[TBL] [Abstract][Full Text] [Related]
9. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of patients with spontaneous rupture of hepatocellular carcinoma.
Miyoshi A; Kitahara K; Kohya N; Noshiro H; Miyazahi K
Hepatogastroenterology; 2011; 58(105):99-102. PubMed ID: 21510294
[TBL] [Abstract][Full Text] [Related]
11. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of hepatectomy-predominant treatment on stage III A hepatocellular carcinoma: a report of 108 cases].
Zhong C; Guo RP; Chen MS; Wei W; Chen ZY
Ai Zheng; 2009 Mar; 28(3):274-8. PubMed ID: 19619442
[TBL] [Abstract][Full Text] [Related]
13. Factors predicting survival in advanced T-staged hepatocellular carcinoma patients treated with reduction hepatectomy followed by transcatheter arterial chemoembolization.
Kobayashi A; Takahashi S; Ishii H; Konishi M; Nakagohri T; Gotohda N; Satake M; Furuse J; Kinoshita T
Eur J Surg Oncol; 2007 Oct; 33(8):1019-24. PubMed ID: 17399939
[TBL] [Abstract][Full Text] [Related]
14. Early intrahepatic recurrence of hepatocellular carcinoma after hepatectomy treated with re-hepatectomy, ablation or chemoembolization: a prospective cohort study.
Wang K; Liu G; Li J; Yan Z; Xia Y; Wan X; Ji Y; Lau WY; Wu M; Shen F
Eur J Surg Oncol; 2015 Feb; 41(2):236-42. PubMed ID: 25434327
[TBL] [Abstract][Full Text] [Related]
15. [Different prognostic factors are associated with early and late intrahepatic recurrence following curative hepatectomy for patients with hepatocellular carcinoma].
Xu W; Li JD; Shi G; Li JS; Dai Y; Wang XF
Zhonghua Wai Ke Za Zhi; 2010 Jun; 48(11):806-11. PubMed ID: 21163046
[TBL] [Abstract][Full Text] [Related]
16. Salvage surgery for uncontrollable hepatocellular carcinoma treated with repeated non-surgical therapies.
Ochiai T; Sonoyama T; Ikoma H; Kuriu Y; Nakanishi M; Kubota T; Kikuchi S; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Kokuba Y; Otsuji E
Hepatogastroenterology; 2010; 57(101):858-64. PubMed ID: 21033242
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors of hepatocellular carcinoma after liver transplantation].
Zhou LX; Yan LN
Ai Zheng; 2006 Jun; 25(6):736-9. PubMed ID: 16764771
[TBL] [Abstract][Full Text] [Related]
18. Predictors and patterns of recurrence after resection of hepatocellular carcinoma.
Cha C; Fong Y; Jarnagin WR; Blumgart LH; DeMatteo RP
J Am Coll Surg; 2003 Nov; 197(5):753-8. PubMed ID: 14585409
[TBL] [Abstract][Full Text] [Related]
19. Prognostic effect of steatosis on hepatocellular carcinoma patients after liver resection.
Wu TH; Yu MC; Chan KM; Lee CF; Chen TC; Chang HC; Chou HS; Wu TJ; Eldeen FZ; Chen MF; Lee WC
Eur J Surg Oncol; 2011 Jul; 37(7):618-22. PubMed ID: 21640545
[TBL] [Abstract][Full Text] [Related]
20. Arabinoxylan rice bran (MGN-3) enhances the effects of interventional therapies for the treatment of hepatocellular carcinoma: a three-year randomized clinical trial.
Bang MH; Van Riep T; Thinh NT; Song le H; Dung TT; Van Truong L; Van Don L; Ky TD; Pan D; Shaheen M; Ghoneum M
Anticancer Res; 2010 Dec; 30(12):5145-51. PubMed ID: 21187503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
